Previous 10 | Next 10 |
GERMANTOWN, Md. , Feb. 20, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, and its wholly-owned subsidiary Precigen, Inc. , a biopharmaceutical ...
In (yet another) statement , FDA Commission Scott Gottlieb, M.D. announces the issuance of final updated guidance for gene therapy and cell therapy developers. More news on: Abeona Therapeutics Inc., Bellicum Pharmaceuticals, ZIOPHARM Oncology, Inc., Healthcare stocks news, Read more ...
GERMANTOWN, Md. , Feb. 11, 2019 /PRNewswire/ -- Precigen, Inc. , a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON) and a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announce...
- The market for cell therapies of all kinds is exploding in size. By 2025 these regenerative medicines are expected to be a $150 billion market globally with a 30%+ growth rate through the first half of the 2020s according to Roland Berger research. The trouble for the hundreds of companie...
POINT ROBERTS, Wa., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Investorideas.com , a leading investor news resource covering hemp and cannabis stocks releases a snapshot of companies investing in new methods of cannabinoid production to meet the growing demands of the future According to Res...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Like action? What a week ahead with a cavalcade of companies due to present across ...
GERMANTOWN, Md. , Jan. 2, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that the company and its subsidiaries will present at upco...
GERMANTOWN, Md. , Dec. 31, 2018 /PRNewswire/ -- Precigen, Inc., a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON) and a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announced that ...
GERMANTOWN, Md. , Dec. 24, 2018 /PRNewswire/ -- Precigen, Inc., a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON), and a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announced...
GERMANTOWN, Md. , Dec. 21, 2018 /PRNewswire/ -- Precigen, Inc., a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON), and a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announced that...
News, Short Squeeze, Breakout and More Instantly...
Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares PR Newswire GERMANTOWN, Md. , Jan. 26, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) announced today the closing of its previously ann...
Pioneer Natural Resources (PXD) is well positioned to benefit from the recovery of the global economy because the demand for oil and natural gas will rise with the resumption of industrial operations. Also, the company’s progress on strategic acquisitions and in providing unique scale ...
Precigen to Present at the 39th Annual J.P. Morgan Healthcare Conference - Management will also participate in a panel discussion at the H.C. Wainwright BioConnect 2021 Conference - PR Newswire GERMANTOWN, Md. , Jan. 6, 2021 /PRNewswire/ -- Precigen, In...